Prenetics Global Limited (Nasdaq: PRE) ("Prenetics" or the "Company"), the parent company of IM8, the premium health and longevity brand co-founded with David Beckham, today announced that Brian J. Rosin will succeed Stephen Lo as Chief Financial Officer of Prenetics, effective December 31, 2026. The Company’s Board of Directors is expected to formalize the appointment at its meeting on November 12, 2026. Mr. Rosin, who joined as Chief Financial Officer of IM8 in May 2026, will serve as Chief Financial Officer-designate of Prenetics through year-end, continuing as Chief Financial Officer of IM8 and working alongside Mr. Lo, and will then lead the Company’s global finance organization and continue to report to Chief Executive Officer Danny Yeung.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.